A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This CML disease registry (ASC4REAL-2) aims to gather evidence on the tolerability, safety, effectiveness, and patient-reported outcomes (PRO) in real-world healthcare from patients with Ph+-CML-CP treated with TKIs approved for 1L and 2L, including prospective follow-up for 5 years identifying and describing long-term treatment outcomes.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat w momencie diagnozy białaczki
- •Przyjmowanie jednego z pięciu zatwierdonych leków (asciminib, bosutinib, dasatinib, imatinib, nilotinib) jako pierwsza linia leczenia lub po jednym wcześniejszym leku
- •Leczenie w placówce medycznej na terenie USA lub terytoriów USA (np. Portoryko)
- •Podpisana zgoda na uczestnictwo w badaniu, w tym na dostęp do anonimowych danych medycznych
✗ Disqualifies
- •Aktualny udział w innym badaniu klinicznym mogącym wpłynąć na leczenie
- •Leczenie trzema lub więcej lekami na białaczkę (trzecia linia i dalsze)
- •Obecność mutacji T315I
- •Faza bez przyjmowania leków (TFR) - bez aktywnego leczenia
- •Historia przeszczepienia szpiku kostnego
- •Ciąża lub karmienie piersią
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 100 Years
- Last updated (source)
- July 20, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (17)
University of Alabama at Birmingham
Birmingham, United States
Stockton Hematology Oncology Medical Group Inc
Stockton, United States
Lundquist Inst BioMed at Harbor
Torrance, United States
Stamford Hospital
Stamford, United States
Sacred Heart Medical Oncology
Pensacola, United States
Cancer Care Specialists of Central Illinois
Decatur, United States
St Agnes Hospital
Baltimore, United States
Truman Medical Center
Kansas City, United States
NY Cancer and Blood Specialists
East Setauket, United States
SUNY Upstate Medical University
Syracuse, United States
Tri-County Hematology and Oncology Associates
Canton, United States
Oregon Oncology Specialists Salem
Salem, United States
Avera Cancer
Sioux Falls, United States
Baylor Scott and White Research
Temple, United States
Fred Hutchinson Cancer Research Center
Seattle, United States
MultiCare Health System Institute
Tacoma, United States
Northwest Medical Specialties
Tacoma, United States
Trial contact
Novartis Pharmaceuticals
Novartis Pharmaceuticals
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/21/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.